AMIT KUMAR

Employment

• University of Pittsburgh School of Medicine PostDoc Researcher
  2023 - Present

Education

• CSIR Institute of Genomics & Integrative Biology PhD
  2016 - 2022
• Indian Institute of Technology Guwahati M.Tech
  2014 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (7)

• Hepatocyte TEAD1 drives epithelial-stromal remodeling during cholestatic liver injury
  Kumar Ar, Jeongkyung Lee, Vinny Negi

  +7 more

  • Varun Mandi
  • Domenic Filingeri
  • Joey Danvers
  • Rajat Pant
  • Samit Ghosh
  • +2 more
  2026 DOI: 10.64898/2026.05.21.726939
  +Save
• 12560 RIMOC1, A Novel Regulator Of Mitochondrial Function, And Its Role In Pancreatic Beta-cell Survival, Mitophagy, And Diabetogenesis
  Journal of the Endocrine Society 2024 DOI: 10.1210/jendso/bvae163.916
  +Save
• Bromodomain Protein Inhibition Protects β-Cells from Cytokine-Induced Death and Dysfunction via Antagonism of NF-κB Pathway
  Cells 2024 DOI: 10.3390/cells13131108
  +Save
• miR-539-5p regulates Srebf1 transcription in the skeletal muscle of diabetic mice by targeting DNA methyltransferase 3b.
  Molecular therapy. Nucleic acids 2022 DOI: 10.1016/j.omtn.2022.08.013
  +Save
• H19 inhibition increases HDAC6 and regulates IRS1 levels and insulin signaling in the skeletal muscle during diabetes.
  Molecular medicine (Cambridge, Mass.) 2022 DOI: 10.1186/s10020-022-00507-3
  +Save
• RNA sequencing reveals potential interacting networks between the altered transcriptome and ncRNome in the skeletal muscle of diabetic mice.
  Bioscience reports 2021 DOI: 10.1042/bsr20210495
  +Save
• Nuclear Factor Kappa B: A Potential Target to Persecute Head and Neck Cancer.
  Javadi Monisha, Nand Kishor Roy, Devivasha Bordoloi +5 more
  Current drug targets 2017 DOI: 10.2174/1389450117666160201112330
  +Save